NYMIVI Trademark

Trademark Overview

On Monday, June 25, 2018, a trademark application was filed for NYMIVI with the United States Patent and Trademark Office. The USPTO has given the NYMIVI trademark a serial number of 88013809. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 31, 2022. This trademark is owned by Grace Therapeutics, Inc.. The NYMIVI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations to treat subarachnoid hemorrhage
nymivi

General Information

Serial Number88013809
Word MarkNYMIVI
Filing DateMonday, June 25, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations to treat subarachnoid hemorrhage

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 30, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGrace Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816
Party NameGrace Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816

Trademark Events

Event DateEvent Description
Monday, January 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 14, 2021EXTENSION 4 GRANTED
Monday, June 14, 2021EXTENSION 4 FILED
Monday, June 14, 2021TEAS EXTENSION RECEIVED
Tuesday, December 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 11, 2020EXTENSION 3 GRANTED
Friday, December 11, 2020EXTENSION 3 FILED
Friday, December 11, 2020TEAS EXTENSION RECEIVED
Saturday, May 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2020EXTENSION 2 GRANTED
Thursday, May 28, 2020EXTENSION 2 FILED
Thursday, May 28, 2020TEAS EXTENSION RECEIVED
Tuesday, November 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 15, 2019EXTENSION 1 GRANTED
Friday, November 15, 2019EXTENSION 1 FILED
Friday, November 15, 2019TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 22, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 22, 2019ASSIGNED TO LIE
Friday, March 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 27, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 15, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, October 15, 2018PRIORITY ACTION E-MAILED
Monday, October 15, 2018PRIORITY ACTION WRITTEN
Monday, October 15, 2018ASSIGNED TO EXAMINER
Saturday, June 30, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 28, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

nymivi hemorrhage subarachnoid treat preparations pharmaceutical